» Authors » P Damkier

P Damkier

Explore the profile of P Damkier including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 26
Citations 333
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Martiny K, Larsen E, Licht R, Nielsen C, Damkier P, Refsgaard E, et al.
Pharmacopsychiatry . 2015 Nov; 48(7):274-8. PMID: 26529118
Introduction: Electroconvulsive treatment (ECT) is an effective treatment for severe depression but carries a risk of relapse in the following months. Methods: Major depressive disorder patients in a current episode...
12.
Larsen E, Damkier P, Pedersen L, Fenger-Gron J, Mikkelsen R, Nielsen R, et al.
Acta Psychiatr Scand Suppl . 2015 Sep; (445):1-28. PMID: 26344706
Objective: To write clinical guidelines for the use of psychotropic drugs during pregnancy and breast-feeding for daily practice in psychiatry, obstetrics and paediatrics. Method: As we wanted a guideline with...
13.
Schjerning O, Lykkegaard S, Damkier P, Nielsen J
Pharmacopsychiatry . 2014 Oct; 48(1):15-8. PMID: 25295553
Introduction: Pregabalin is an antiepileptic drug with anti-anxiety properties and is approved for treatment of generalized anxiety disorder. Anxiety is common in patients with schizophrenia and pregabalin has been suggested...
14.
Broe A, Pottegard A, Lamont R, Jorgensen J, Damkier P
BJOG . 2014 Apr; 121(8):988-96. PMID: 24754708
Objective: The aim of this study was to describe the use of antibiotics in a national population-based cohort of pregnant Danish women between 2000 and 2010. Design: Register-based, population-wide, cohort...
15.
Nielsen J, Damkier P, Lublin H, Taylor D
Acta Psychiatr Scand . 2011 May; 123(6):411-22. PMID: 21534935
Objective: Clozapine treatment remains the gold standard for treatment-resistant schizophrenia, but treatment with clozapine is associated with several side-effects that complicate the use of the drug. This clinical overview aims...
16.
Bergmann T, Brasch-Andersen C, Green H, Mirza M, Pedersen R, Nielsen F, et al.
Pharmacogenomics J . 2010 Apr; 11(2):113-20. PMID: 20368717
The primary purpose of this study was to evaluate the effect of CYP2C8*3 and three genetic ABCB1 variants on the elimination of paclitaxel. We studied 93 Caucasian women with ovarian...
17.
Noehr-Jensen L, Zwisler S, Larsen F, Sindrup S, Damkier P, Brosen K
Clin Pharmacol Ther . 2009 Aug; 86(6):626-33. PMID: 19710642
Tramadol is O-demethylated to the active metabolite (+)-O-desmethyltramadol ((+)-M1) via CYP2D6, an enzyme that is weakly inhibited by escitalopram. We investigated the possibility of a pharmacokinetic (PK) and pharmacodynamic (PD)...
18.
Noehr-Jensen L, Zwisler S, Larsen F, Sindrup S, Damkier P, Nielsen F, et al.
Eur J Clin Pharmacol . 2009 May; 65(9):887-94. PMID: 19404631
Purpose: To investigate the impact of cytochrome P450 2C19 (CYP2C19) phenotypes on escitalopram metabolism and to evaluate pupillometry as a serotonergic biomarker. Methods: This was a double-blind, crossover design study...
19.
Hedegaard U, Damkier P
Eur J Clin Pharmacol . 2009 Jan; 65(5):515-22. PMID: 19137281
Purpose: Problem-oriented drug information (POD) is a service in which health professionals provide evidence-based answers to clinical questions posed by physicians. The objective of this study was to evaluate the...
20.
Hedegaard F, Damkier P
Ugeskr Laeger . 2002 Jan; 163(47):6567. PMID: 11760535
No abstract available.